Federal Register #B-100-2026

Proposed Production Activity: Viatris Pharmaceuticals Medication Manufacturing in FTZ 61, Puerto Rico

This opportunity concerns a proposed production activity notification from Viatris Pharmaceuticals LLC to the Foreign-Trade Zones Board (Commerce Department) for its facility in Vega Baja, Puerto Rico (FTZ 61). - Government Buyer: - U.S. Department of Commerce, Foreign-Trade Zones Board - OEM: - Viatris Pharmaceuticals LLC (manufacturer of the medications) - Products/Services Requested: - Manufacturing of a wide range of medications in tablet and capsule form, including: - Ativan, Lipitor, Xanax, Atorvastatin, Celebrex, Colestid, Detrol, Dilantin, Effexor, Eplerenone, Ibrance, Inspra, Lorbrena, Lorviqua, Lyrica, Neurontin, Nitrostat, Norvasc, Pristiq, Vizimpro, Xeljanz, Zithromax, Zyvox - Use of specific foreign-status materials and active pharmaceutical ingredients (APIs), such as: - Amlodipine besylate, atorvastatin, azithromycin, celecoxib, eplerenone, gabapentin, pregabalin, propranolol, disopyramide, linezolid, and others - Bulk tablets, capsules, microcrystalline cellulose, mini bags, pharmatose, tabbletose, rapamune tablets - Unique/Notable Requirements: - Some materials are subject to duties under section 232 of the Trade Expansion Act of 1962, depending on country of origin - Such materials must be admitted to FTZs in privileged foreign status - No specific purchase quantities or part numbers provided - Public comments are invited on the proposed activity

Description

Viatris Pharmaceuticals LLC submitted a notification of proposed production activity to the Foreign-Trade Zones Board for its facility in Vega Baja, Puerto Rico within FTZ 61. The production activity involves manufacturing various medications including tablets and capsules such as Ativan, Lipitor, and Xanax. The notification specifies the use of certain foreign-status materials and components, some of which are subject to duties under section 232 of the Trade Expansion Act of 1962. Public comments on the proposed production activity are invited until September 21, 2026.

View original listing